Different subtypes of EGFR exon19 mutation can affect prognosis of patients with non-small cell lung adenocarcinoma
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Different subtypes of EGFR exon19 mutation can affect prognosis of patients with non-small cell lung adenocarcinoma
Authors
Keywords
Mutation, Non-small cell lung cancer, Adenocarcinoma of the lung, Adenocarcinomas, Point mutation, Deletion mutation, Mutation detection, Substitution mutation
Journal
PLoS One
Volume 13, Issue 11, Pages e0201682
Publisher
Public Library of Science (PLoS)
Online
2018-11-02
DOI
10.1371/journal.pone.0201682
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mutation abundance affects the therapeutic efficacy of EGFR-TKI in patients with advanced lung adenocarcinoma: A retrospective analysis
- (2018) Huijuan Wang et al. CANCER BIOLOGY & THERAPY
- EGFR Mutation Subtypes Influence Survival Outcomes following First-Line Gefitinib Therapy in Advanced Asian NSCLC Patients
- (2017) Natalia Sutiman et al. Journal of Thoracic Oncology
- Characterization of common and rare mutations in EGFR and associated clinicopathological features in a large population of Chinese patients with lung cancer
- (2017) Bing Wei et al. PATHOLOGY RESEARCH AND PRACTICE
- Prognostic value of plasma EGFR ctDNA in NSCLC patients treated with EGFR-TKIs
- (2017) Chengjuan Zhang et al. PLoS One
- Comparison of therapeutic effects of EGFR-tyrosine kinase inhibitors on 19Del and L858R mutations in advanced lung adenocarcinoma and effect on cellular immune function
- (2017) Juan Zhou et al. Thoracic Cancer
- Prevalence and Clinical Profile of EGFR Mutation In Non-Small-Cell Lung Carcinoma Patients in Southwest China
- (2016) Juan Zhou et al. Asian Pacific Journal of Cancer Prevention
- An Analysis of EGFR Mutations among 1506 Cases of Non-Small Cell Lung Cancer Patients in Guangxi, China
- (2016) Wen-E Wei et al. PLoS One
- Rationale and Study Design of the IRENE-Trial (NVALT-16): A Phase II Trial to Evaluate Iressa Rechallenge in Advanced NSCLC Patients With an Activating EGFR Mutation Who Responded to an EGFR-TKI Used As First-Line or Previous Treatment
- (2015) Justine L. Kuiper et al. Clinical Lung Cancer
- Is there evidence for different effects among EGFR-TKIs? Systematic review and meta-analysis of EGFR tyrosine kinase inhibitors (TKIs) versus chemotherapy as first-line treatment for patients harboring EGFR mutations
- (2015) Eva Regina Haspinger et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Non-invasive approaches to monitor EGFR-TKI treatment in non-small-cell lung cancer
- (2015) Wei Sun et al. Journal of Hematology & Oncology
- Prognostic Significance of Genotype and Number of Metastatic Sites in Advanced Non–Small-Cell Lung Cancer
- (2014) Yan-yan He et al. Clinical Lung Cancer
- Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors vs Conventional Chemotherapy in Non–Small Cell Lung Cancer Harboring Wild-Type Epidermal Growth Factor Receptor
- (2014) June-Koo Lee et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Different efficacy of EGFR tyrosine kinase inhibitors and prognosis in patients with subtypes of EGFR-mutated advanced non-small cell lung cancer: a meta-analysis
- (2014) Huan Wang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Patients with Exon 19 Deletion Were Associated with Longer Progression-Free Survival Compared to Those with L858R Mutation after First-Line EGFR-TKIs for Advanced Non-Small Cell Lung Cancer: A Meta-Analysis
- (2014) Yaxiong Zhang et al. PLoS One
- Molecular Predictors of EGFR-TKI Sensitivity in Advanced Non–small Cell Lung Cancer
- (2012) Xiaozhu Zhang et al. International Journal of Medical Sciences
- EGFR Gene Alterations in a Norwegian Cohort of Lung Cancer Patients Selected for Surgery
- (2011) Åslaug Helland et al. Journal of Thoracic Oncology
- Staging of non-small cell lung cancer (NSCLC): A review
- (2010) S. Tsim et al. RESPIRATORY MEDICINE
- Frequency of and variables associated with the EGFR mutation and its subtypes
- (2009) Tomoaki Tanaka et al. INTERNATIONAL JOURNAL OF CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now